Bank Of America Corp Opiant Pharmaceuticals, Inc. Transaction History

Bank Of America Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$9.38 - $20.29 $10,036 - $21,710	1,070 New	1,070 $21,000
Q2 2022 Aug 12, 2022	BUY	$10.12 - $23.32 $1,335 - $3,078	132 Added 52.38%	384 $4,000
Q4 2021 Feb 08, 2022	SELL	$22.51 - $36.79 $292 - $478	-13 Reduced 4.91%	252 $8,000
Q3 2021 Nov 15, 2021	BUY	$13.28 - $25.79 $172 - $335	13 Added 5.16%	265 $6,000
Q2 2021 Sep 13, 2021	BUY	$10.5 - $14.19 $2,646 - $3,575	252 New	252 $3,000

300

Ticker OPNT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 5,164,150
Description
Opiant Pharmaceuticals, Inc., a specialty pharmaceutical company, develops medicines for addictions and drug overdose. The company offers NARCAN nasal spray, a treatment to reverse opioid overdoses. Its pipeline of product candidates includes medicines for the treatment for opioid overdose reversal; alcohol use disorders; acute cannabinoid overd...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.